Oncotarget

Research Perspectives:

The Interfaces Between Signal Transduction Pathways: IGF-1/mTor, p53 and the Parkinson Disease Pathway

Arnold J. Levine _, Chris R. Harris, Anna M. Puzio-Kuter

PDF  |  HTML  |  Order a Reprint

Oncotarget. 2012; 3:1301-1307. https://doi.org/10.18632/oncotarget.759

Metrics: PDF 1315 views  |   HTML 1101 views  |   ?  


Abstract

Arnold J. Levine1, Chris R. Harris1 and Anna M. Puzio-Kuter1

1 Cancer Institute of New Jersey, UMDNJ, New Brunswick, N.J.

Correspondence:

Arnold J. Levine, email:

Keywords: p53, parkinson disease, IGF-1, mTOR, RHEB

Received: November 20, 2012, Accepted: November 27, 2012, Published: November 28, 2012


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 759